BRIEF RESEARCH REPORT
Published on 15 Mar 2023
Canakinumab leads to rapid reduction of neutrophilic inflammation and long-lasting response in Schnitzler syndrome
doi 10.3389/fmed.2023.1050230
- 1,411 views
- 2 citations
11k
Total downloads
55k
Total views and downloads
BRIEF RESEARCH REPORT
Published on 15 Mar 2023
REVIEW
Published on 23 Feb 2023
SYSTEMATIC REVIEW
Published on 16 Feb 2023
SYSTEMATIC REVIEW
Published on 15 Dec 2022
ORIGINAL RESEARCH
Published on 29 Sep 2022
ORIGINAL RESEARCH
Published on 29 Aug 2022
CASE REPORT
Published on 29 Apr 2022
SYSTEMATIC REVIEW
Published on 25 Jan 2022
ORIGINAL RESEARCH
Published on 22 Mar 2021
SYSTEMATIC REVIEW
Published on 03 Nov 2020